Search Results - "LEBREC, DIDIER"

Refine Results
  1. 1
  2. 2

    Clinical classification of pulmonary hypertension by Simonneau, Gerald, Galiè, Nazzareno, Rubin, Lewis J, Langleben, David, Seeger, Werner, Domenighetti, Guido, Gibbs, Simon, Lebrec, Didier, Speich, Rudolf, Beghetti, Maurice, Rich, Stuart, Fishman, Alfred

    “…In 1998, during the Second World Symposium on Pulmonary Hypertension (PH) held in Evian, France, a clinical classification of PH was proposed. The aim of the…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list by Prié, Dominique, Forand, Anne, Francoz, Claire, Elie, Caroline, Cohen, Isabelle, Courbebaisse, Marie, Eladari, Dominique, Lebrec, Didier, Durand, François, Friedlander, Gerard

    Published in PloS one (25-06-2013)
    “…High plasma fibroblast growth factor-23 (FGF23) concentration predicts the risk of death and poor outcomes in patients with chronic kidney disease or chronic…”
    Get full text
    Journal Article
  4. 4

    Meta-analyses of FibroTest diagnostic value in chronic liver disease by Poynard, Thierry, Morra, Rachel, Halfon, Philippe, Castera, Laurent, Ratziu, Vlad, Imbert-Bismut, Françoise, Naveau, Sylvie, Thabut, Dominique, Lebrec, Didier, Zoulim, Fabien, Bourliere, Marc, Cacoub, Patrice, Messous, Djamila, Munteanu, Mona, de Ledinghen, Victor

    Published in BMC gastroenterology (15-10-2007)
    “…FibroTest (FT) is a biomarker of liver fibrosis initially validated in patients with chronic hepatitis C (CHC). The aim was to test two hypotheses, one, that…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Diagnosis and treatment of acute renal failure in patients with cirrhosis by Moreau, Richard, MD, Lebrec, Didier, MD

    “…In patients with cirrhosis, acute renal failure is due to prerenal failure (a result of decreased renal perfusion) and tubular necrosis. There are 3 main…”
    Get full text
    Journal Article
  8. 8

    Clinicopathological forms and prognostic index in Budd-Chiari syndrome by Langlet, Philippe, Escolano, Sylvie, Valla, Dominique, Coste-Zeitoun, Delphine, Denie, Cecile, Mallet, Alain, Levy, Victor-Georges, Franco, Dominique, Vinel, Jean-Pierre, Belghiti, Jacques, Lebrec, Didier, Hay, Jean-Marie, Zeitoun, Guy

    Published in Journal of hepatology (01-10-2003)
    “…Background: A recent study in patients with Budd-Chiari syndrome showed the value of a prognostic index including age, Pugh score, ascites and serum…”
    Get full text
    Journal Article
  9. 9

    Prevention of Gram-Negative Translocation Reduces the Severity of Hepatopulmonary Syndrome by Rabiller, Anne, Nunes, Hilario, Lebrec, Didier, Tazi, Khalid A, Wartski, Myriam, Dulmet, Elisabeth, Libert, Jean-Marie, Mougeot, Christine, Moreau, Richard, Mazmanian, Michel, Humbert, Marc, Herve, Philippe

    “…Hepatopulmonary syndrome (HPS) is characterized by intrapulmonary vascular dilatations and an increased alveoloarterial oxygen difference (AaPO(2)). These…”
    Get full text
    Journal Article
  10. 10

    Role of Nitric Oxide in Hepatopulmonary Syndrome in Cirrhotic Rats by NUNES, HILARIO, LEBREC, DIDIER, MAZMANIAN, MICHEL, CAPRON, FREDERIQUE, HELLER, JORG, TAZI, KHALID A, ZERBIB, ERIC, DULMET, ELISABETH, MOREAU, RICHARD, DINH-XUAN, A. TUAN, SIMONNEAU, GERALD, HERVE, PHILIPPE

    “…The hepatopulmonary syndrome (HPS) is characterized by intrapulmonary vascular dilatations and an increased alveolar-arterial oxygen difference (AaPO(2))…”
    Get full text
    Journal Article
  11. 11

    Discrepant effects of inducible nitric oxide synthase modulation on systemic and splanchnic endothelial nitric oxide synthase activity and expression in cirrhotic rats by Malyshev, Eugene, Tazi, Khalid A, Moreau, Richard, Lebrec, Didier

    Published in Journal of gastroenterology and hepatology (01-12-2007)
    “…Background:  Arterial vasodilatation, which is a major factor in the pathogenesis of the hyperkinetic circulatory state and portal hypertension in cirrhosis,…”
    Get full text
    Journal Article
  12. 12
  13. 13

    The future treatment of portal hypertension by Reichen, Jürg, MD, Lebrec, Didier, MD

    “…Increased understanding of the hyperdynamic circulation syndrome has resulted in novel therapeutic approaches, some of which have already reached clinical…”
    Get full text
    Journal Article
  14. 14

    Protein array technology to investigate cytokine production by monocytes from patients with advanced alcoholic cirrhosis: An ex vivo pilot study by Tazi, Khalid A., Quioc, Jean-Jacques, Abdel-Razek, Wael, Tellier, Zéra, Guichard, Cécile, Ogier-Denis, Eric, Lebrec, Didier, Moreau, Richard

    Published in Hepatology research (01-07-2009)
    “…Aim:  In patients with advanced cirrhosis, little is known about the ability of peripheral blood monocytes to spontaneously produce signaling proteins such as…”
    Get full text
    Journal Article
  15. 15

    Noninvasive assessment of portal hypertension in patients with cirrhosis by Thabut, Dominique, Moreau, Richard, Lebrec, Didier

    Published in Hepatology (Baltimore, Md.) (01-02-2011)
    “…Severe portal hypertension is responsible for complications and death. Although measurement of the hepatic venous pressure gradient is the most accurate method…”
    Get full text
    Journal Article
  16. 16

    Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics by Hadengue, A, Benhayoun, M K, Lebrec, D, Benhamou, J P

    Published in Gastroenterology (New York, N.Y. 1943) (01-02-1991)
    “…The prevalence of pulmonary hypertension in 507 patients hospitalized with portal hypertension but without known pulmonary hypertension who underwent cardiac…”
    Get more information
    Journal Article
  17. 17

    Autophagy in liver diseases by Rautou, Pierre-Emmanuel, Mansouri, Abdellah, Lebrec, Didier, Durand, François, Valla, Dominique, Moreau, Richard

    Published in Journal of hepatology (01-12-2010)
    “…Autophagy, or cellular self-digestion, is a cellular pathway crucial for development, differentiation, survival, and homeostasis. Its implication in human…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Severe sepsis in cirrhosis by Gustot, Thierry, Durand, François, Lebrec, Didier, Vincent, Jean‐Louis, Moreau, Richard

    Published in Hepatology (Baltimore, Md.) (01-12-2009)
    “…Sepsis is physiologically viewed as a proinflammatory and procoagulant response to invading pathogens. There are three recognized stages in the inflammatory…”
    Get full text
    Journal Article
  20. 20

    Deleterious effects of beta‐blockers on survival in patients with cirrhosis and refractory ascites by Sersté, Thomas, Melot, Christian, Francoz, Claire, Durand, François, Rautou, Pierre‐Emmanuel, Valla, Dominique, Moreau, Richard, Lebrec, Didier

    Published in Hepatology (Baltimore, Md.) (01-09-2010)
    “…Beta‐blockers may have a negative impact on survival in patients with cirrhosis and refractory ascites. The aim of this study was to evaluate the effect of the…”
    Get full text
    Journal Article